KLRK1 and prostate cancer: The results showed that NKG2D-CAR T cells exhibited significant cytolytic activity against several prostate cancer cell lines in an E:T ratio-dependent manner, but had no killing effect on the NKG2DLs− cell line B16-F10 (Figure 1b).